Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0LS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,157
Award facts
- Contract value 100% obligated
- $30,156.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency awarded a $30,156.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Stelara 45 mg/0.5 mL syringes. This non-set-aside contract, with an ultimate completion date of January 15, 2026, supports pharmaceutical supply to federal medical procurement needs. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical vendor in the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply an extensive portfolio of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The firm fixed-price structure and non-set-aside nature of this delivery order demonstrate the company's capability to meet federal procurement requirements through open competition, consistent with its role as a significant pharmaceutical distributor supporting Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FR0LS?
SPE2DR26FR0LS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FR0LS worth?
The government has obligated $30,157 on SPE2DR26FR0LS.
Is contract SPE2DR26FR0LS an order under another contract?
Yes. SPE2DR26FR0LS is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0LS competed?
The extent of competition for SPE2DR26FR0LS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award